Study Unveils Alarming Rise in Men's Polypharmacy
A recent study has revealed a concerning trend: the number of men taking multiple medications has surged in the past decade, surpassing women in this practice. The research, conducted by PhD student Georgie Lee from The University of Western Australia, analyzed polypharmacy rates among men and women across various age groups in Australia from 2013 to 2024. The findings were eye-opening, showing a significant increase from 8% to 9.2% in polypharmacy prevalence.
In 2024, nearly two million Australians were affected by polypharmacy, with a staggering 30% of those aged 65 or older and 3.4% of those under 65 regularly taking five or more medicines. This trend is particularly alarming as it can lead to increased side effects, harmful interactions, and hospital visits.
The study's key revelation was that while polypharmacy was previously more prevalent among women, the recent growth is predominantly driven by men. Interestingly, the prevalence among women remained relatively stable. This shift suggests that men are starting to adopt multiple medications earlier in life, with older adults still accounting for the majority of polypharmacy cases (approximately 70%).
Senior author Dr. Amy Page emphasized the importance of awareness regarding these trends. She believes that understanding these patterns can empower consumers to recognize the significance of regular medication reviews. Dr. Page encourages individuals to actively engage in conversations with their healthcare providers about their prescriptions.
Furthermore, she highlights the role of healthcare professionals and policymakers in utilizing this information to tailor care and develop targeted strategies. By identifying those most at risk, Australians can ensure safer medication use throughout their lives. However, the study also serves as a reminder that while stabilizing or declining polypharmacy among older women is positive, careful monitoring and holistic medication management are essential to prevent harm.
This research underscores the critical need for regular reviews to maintain the safety and appropriateness of treatments over time.
